Home/Filings/4/0001209191-16-150890
4//SEC Filing

Intra-Cellular Therapies, Inc. 4

Accession 0001209191-16-150890

CIK 0001567514operating

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 4:35 PM ET

Size

5.3 KB

Accession

0001209191-16-150890

Insider Transaction Report

Form 4
Period: 2016-11-14
ALAFI MOSHE
10% Owner
Transactions
  • Purchase

    Common Stock

    2016-11-14$14.50/sh+34,000$492,9693,630,205 total(indirect: By LLC)
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.41 to $14.50, inclusive.
  • [F2]Mr. Alafi is a managing partner of Alafi Capital Company, LLC and may be deemed to beneficially own the shares held by Alafi Capital Company, LLC. Mr. Alafi disclaims beneficial ownership of the securities held by Alafi Capital Company, LLC except to the extent of his pecuniary interest therein.

Issuer

Intra-Cellular Therapies, Inc.

CIK 0001567514

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001567514

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:35 PM ET
Size
5.3 KB